Kymera Therapeutics (KYMR) Other Working Capital Changes (2019 - 2026)
Kymera Therapeutics (KYMR) posted quarterly Other Working Capital Changes of -$2.2 million for Q1 2026, down 410.23% year-over-year from $694000.0 in Q1 2025, and up 25.01% quarter-over-quarter from -$2.9 million in Q4 2025.
Kymera Therapeutics (KYMR) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Kymera Therapeutics (KYMR) has reported Other Working Capital Changes for 8 consecutive years, with -$2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 410.23% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at $17.9 million (up 2610.27% YoY), while the FY2025 annual figure was $20.8 million, up 6806.13% from the prior year.
- Other Working Capital Changes improved to -$2.2 million in Q1 2026 per KYMR's latest filing, from -$2.9 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $14.2 million in Q4 2023 and bottomed at -$5.2 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged $1.2 million across 5 years, with a median of $480000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 3914.04% in 2025 and fell as far as 1350.0% in 2025.
- Kymera Therapeutics' Other Working Capital Changes stood at $24.4 million in 2022, then tumbled by 97.91% to $511000.0 in 2023, then slumped by 138.75% to -$198000.0 in 2024, then sank by 1350.0% to -$2.9 million in 2025, then increased by 25.01% to -$2.2 million in 2026.
- Business Quant data shows KYMR's Other Working Capital Changes at -$2.2 million in Q1 2026, -$2.9 million in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kymera Therapeutics | 9.72 Bn | 9.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -223,000.00 |
| Jun 30, 2026 | -223,000.00 |
| Jun 30, 2026 | -223,000.00 |
| Mar 31, 2026 | 3.57 Mn |
| Mar 31, 2026 | 3.57 Mn |
| Mar 31, 2026 | 3.57 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.30 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |